Stock 4559 ZERIA PHARMACEUTICAL CO., LTD.
Add to a list
To use this feature you must be a member
Log inSign up

Company Zeria Pharmaceutical Co., Ltd.

Equities

4559

JP3428850006

Pharmaceuticals

Market Closed - Japan Exchange
Other stock markets
 02:00:00 2024-04-25 am EDT 		5-day change 1st Jan Change
2,048 JPY -0.73% Intraday chart for Zeria Pharmaceutical Co., Ltd. +0.34% +1.54%
Apr. 23 Borsch Med Pte. Ltd. Introduces Chondroitin Supplements of Zeria Pharmaceutical Co. Ltd to Singapore for Healthy Joints CI
Feb. 16 Zeria Pharmaceutical's Profit Up 41% in Fiscal Q1-Q3 MT

Business Summary

Zeria Pharmaceutical Co Ltd is a Japan-based company mainly engaged in the development of ethical drug business, consumer healthcare business and other business. The Company operates in two business segments. The Ethical Drug segment is engaged in the research, development, manufacture and sale of ethical drugs. The Consumer Healthcare segment is engaged in the manufacture, purchase and sale of over-the-counter (OTC) drugs, health foods, quasi drugs and cosmetics related to self-medication. The others include insurance agency business and real estate business, as well as various maintenance business such as purchasing and sale of promotional materials.

Number of employees: 1,729

Sales per Business

JPY in Million2022Weight2023Weight Delta
Ethical Pharmaceutical
63.1 %
37,006 62.2 % 43,145 63.1 % +16.59%
Consumer Healthcare
36.7 %
22,370 37.6 % 25,086 36.7 % +12.14%
Other
0.2 %
157 0.3 % 152 0.2 % -2.78%

Sales per region

JPY in Million2022Weight2023Weight Delta
Japan
52.6 %
34,864 58.6 % 36,001 52.6 % +3.26%
Europe
29.5 %
20,954 35.2 % 20,153 29.5 % -3.82%
United Kingdom
10.7 %
-- 7,328 10.7 % -
Other
7.2 %
3,715 6.2 % 4,902 7.2 % +31.95%

Managers

Managers TitleAgeSince
Sachiaki Ibe CEO
 Chief Executive Officer 83 72-02-29
Mitsuhiro Ibe PSD
 President 52 10-03-31
Yoshihiro Hiraga CTO
 Chief Tech/Sci/R&D Officer 66 85-05-31
Yuki Okazawa BRD
 Director/Board Member 59 17-09-30
Yoshiharu Ishiyama AUD
 Comptroller/Controller/Auditor 65 12-06-30
Kenji Kusano SAM
 Sales & Marketing 60 86-03-31
Toshiaki Kawagoe PRN
 Corporate Officer/Principal 63 84-03-31
Hiroki Kato PRN
 Corporate Officer/Principal 61 88-03-31
Hirokazu Endo AUD
 Comptroller/Controller/Auditor 70 05-12-31

Members of the board

Members of the board TitleAgeSince
Sachiaki Ibe CEO
 Chief Executive Officer 83 72-02-29
Tetsuo Komori BRD
 Director/Board Member 76 06-05-31
Yoshihiro Hiraga CTO
 Chief Tech/Sci/R&D Officer 66 85-05-31
Mitsuhiro Ibe PSD
 President 52 10-03-31
Hiroki Kato PRN
 Corporate Officer/Principal 61 88-03-31
Toshiaki Kawagoe PRN
 Corporate Officer/Principal 63 84-03-31
Kikuo Nomoto BRD
 Director/Board Member 87 17-05-31
Kenji Kusano SAM
 Sales & Marketing 60 86-03-31
Seiji Morimoto BRD
 Director/Board Member 73 20-06-25
Yuki Okazawa BRD
 Director/Board Member 59 17-09-30

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 0 53,119,190 29,587,059 ( 55.70 %) 9,039,254 ( 17.02 %) 55.70 %

Shareholders

NameEquities%Valuation
ZERIA PHARMACEUTICAL CO., LTD.
17.02 %
9,039,100 17.02 % 127 M ¥
Ibe Family
8.925 %
4,741,000 8.925 % 67 M ¥
MITSUBISHI UFJ FINANCIAL GROUP, INC
4.969 %
2,639,297 4.969 % 37 M ¥
SUMITOMO MITSUI FINANCIAL GROUP, INC.
4.343 %
2,307,031 4.343 % 32 M ¥
MORINAGA MILK INDUSTRY CO., LTD.
3.464 %
1,840,000 3.464 % 26 M ¥
Sachiaki Ibe
2.997 %
1,592,000 2.997 % 22 M ¥
MIZUHO FINANCIAL GROUP, INC.
2.647 %
1,406,000 2.647 % 20 M ¥
RESONA HOLDINGS, INC.
2.226 %
1,182,385 2.226 % 17 M ¥
MS&AD INSURANCE GROUP HOLDINGS, INC.
1.777 %
944,000 1.777 % 13 M ¥
KISSEI PHARMACEUTICAL CO., LTD.
1.632 %
867,000 1.632 % 12 M ¥

Holdings

NameEquities%Valuation
ZERIA PHARMACEUTICAL CO., LTD.
17.02%
 9,039,100 17.02% 127,333,982 $
ASKA PHARMACEUTICAL HOLDINGS CO.,LTD.
6.14%
 1,877,000 6.14% 27,520,330 $
SUMITOMO REALTY & DEVELOPMENT CO., LTD.
0.04%
 189,000 0.04% 7,239,307 $
KISSEI PHARMACEUTICAL CO., LTD.
0.54%
 267,800 0.54% 6,255,066 $
RIKEN VITAMIN CO., LTD.
0.77%
 258,800 0.77% 4,408,381 $
ONO PHARMACEUTICAL CO., LTD.
0.03%
 146,800 0.03% 2,380,789 $
HOKUYAKU TAKEYAMA HOLDINGS,INC.
1.19%
 289,418 1.19% 1,663,708 $
NIPPON CHEMIPHAR CO., LTD.
2.84%
 121,000 2.84% 1,318,372 $
YUKI GOSEI KOGYO CO., LTD.
2.20%
 483,000 2.20% 1,011,668 $
MATSUKIYOCOCOKARA & CO.
0.01%
 55,185 0.01% 889,516 $

Company contact information

Zeria Pharmaceutical Co., Ltd.

10-11 Nihonbashi Kobuna-cho Chuo-Ku

103-8351, Tokyo

+

http://www.zeria.co.jp
address Zeria Pharmaceutical Co., Ltd.(4559)

Sector

Healthcare
Pharmaceuticals & Medical Research
Pharmaceuticals
Pharmaceuticals
Generic Pharmaceuticals

Sales per Business

Sales per region

Ratings for Zeria Pharmaceutical Co., Ltd.

Trading Rating
Investor Rating
ESG Refinitiv
More Ratings

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
2,063 JPY
Average target price
2,810 JPY
Spread / Average Target
+36.21%
Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Generic Pharmaceuticals

1st Jan change Capi.
ZERIA PHARMACEUTICAL CO., LTD. Stock Zeria Pharmaceutical Co., Ltd.
+1.54% 586M
OTSUKA HOLDINGS CO., LTD. Stock Otsuka Holdings Co., Ltd.
+18.59% 22.25B
SANDOZ GROUP AG Stock Sandoz Group AG
+13.86% 14.39B
CIPLA LIMITED Stock Cipla Limited
+12.83% 13.55B
ZYDUS LIFESCIENCES LIMITED Stock Zydus Lifesciences Limited
+38.02% 11.27B
ONO PHARMACEUTICAL CO., LTD. Stock Ono Pharmaceutical Co., Ltd.
-9.80% 6.95B
THE MEDICINES COMPANY Stock The Medicines Company
-0.05% 6.79B
STADA ARZNEIMITTEL Stock STADA Arzneimittel
-8.87% 5.73B
ASPEN PHARMACARE HOLDINGS LIMITED Stock Aspen Pharmacare Holdings Limited
+6.29% 5.01B
SHENZHEN SALUBRIS PHARMACEUTICALS CO., LTD. Stock Shenzhen Salubris Pharmaceuticals Co., Ltd.
-8.24% 4.51B
Generic Pharmaceuticals
  1. Stock Market
  2. Equities
  3. 4559 Stock
  4. Company Zeria Pharmaceutical Co., Ltd.